Market Place
Sourcing Support
New Proteomics Data Offering Joins Genomic Discovery Alliance
05 Mar 2026 //
PR NEWSWIRE
Takara Bio USA and Illumina Collaborate on Spatial Biology
26 Feb 2026 //
PHARMIWEB
Illumina Partners Drive Cancer Breakthroughs with Spatial Biology
25 Feb 2026 //
PR NEWSWIRE
Illumina Launches Trupath Genome, Redefining Genomic Insight
24 Feb 2026 //
PR NEWSWIRE
Illumina Launches Billion Cell Atlas For AI And Drug Discovery
13 Jan 2026 //
PR NEWSWIRE
Illumina WGS Reveals Genetic Signals in Common Diseases
12 Nov 2025 //
PR NEWSWIRE
Illumina Enhances NGS Proteomics Precision For 40+ Customers
10 Nov 2025 //
PR NEWSWIRE
Iambic Secures $100M+ To Advance AI-Discovered Therapeutics
10 Nov 2025 //
BUSINESS WIRE
Hepta Launches Liquid Biopsy AI Detecting Liver Disease Insights
05 Nov 2025 //
BUSINESSWIRE
Signios Bio, Illumina Name Winners of Joint Proteomics Grant
28 Oct 2025 //
PR NEWSWIRE
Illumina Fuels Multiomic Discovery with Launch of 5-Base Solution
15 Oct 2025 //
PR NEWSWIRE BIO
Illumina Launches AI Informatics Business For Multi-Omics Data
01 Oct 2025 //
PR NEWSWIRE
Illumina Launches Protein Prep to Enhance Drug Discovery
03 Sep 2025 //
PR NEWSWIRE
Infinity Bio secures $8M Series A led by Illumina Ventures
18 Jun 2025 //
BUSINESSWIRE
Signios Bio, Illumina Grant to Maximize NGS Proteomics Panel
19 May 2025 //
BUSINESSWIRE
Illumina board adds activist investor, names Gottlieb chair
25 Mar 2025 //
FIERCE BIOTECH
Illumina rolls out single-flow cell kits for low-volume labs
10 Jan 2025 //
FIERCE BIOTECH
Ovation.io & Illumina Collab to Advance Genomic Data Research
17 Dec 2024 //
BUSINESSWIRE
Myriad Genetics Integrates HRD Platform In Illumina’s Assay
20 Nov 2024 //
GLOBENEWSWIRE
Illumina updates benchtop sequencer with push-button workflows
10 Oct 2024 //
FIERCE BIOTECH
Illumina`s pitch for new machines: You, too, can sequence DNA
09 Oct 2024 //
ENDPTS
FDA Approves Illumina`s Pan-Cancer Companion Diagnostic Test
28 Aug 2024 //
FIERCE BIOTECH
Illumina Expects Core Segment Sales Decline Due To Biotech Crunch
07 Aug 2024 //
REUTERS
Chinese rival to Illumina struggles with US expansion
14 Feb 2024 //
ENDPTS
Illumina receives EU order to divest Grail
12 Oct 2023 //
ENDPTS
Myriad Genetics and Illumina Achieve Milestones in Partnership to Support Trials
19 Sep 2023 //
GLOBENEWSWIRE
Illumina slashes outlook for 2023, two executives depart
09 Aug 2023 //
ENDPTS
MedGenome acquires Illumina`s NovaSeq X Plus & Launches Sequencing Test KaryoSeq
11 Jul 2023 //
PR NEWSWIRE
As it searches for a new CEO, Illumina faces a high-stakes year of challenges
29 Jun 2023 //
ENDPTS
Illumina CEO Francis deSouza resigns, following challenge by activist investor
11 Jun 2023 //
ENDPTS
Acrobat, NanoString, and Illumina Accelerator Collaborate with Stanford Medicine
08 Jun 2023 //
BUSINESSWIRE
Illumina chairman ousted from board as activist investor Icahn wins victory
25 May 2023 //
ENPTS
Severe Flaws In Illumina DNA Sequencing Technology, CISA Warns
28 Apr 2023 //
INFORMATION SECURITY
FDA warns some Illumina DNA sequencing devices could be vulnerable to hackers
28 Apr 2023 //
ENDPTS
Illumina, Henry Ford to explore DNA testing for heart disease
17 Apr 2023 //
FIERCE BIOTECH
Illumina and GenoScreen Launch Sequencing Innovation to Eliminate Tuberculosis
24 Mar 2023 //
PR NEWSWIRE
Illumina and Myriad expand partnership to broaden access to HRD testing
02 Mar 2023 //
GLOBENEWSWIRE
After a bad quarter, Illumina focuses on new DNA sequencing platform
08 Feb 2023 //
ENDPTS
Amgen, Illumina, and Nashville Biosciences Announce Genome Sequencing Agreement
27 Jan 2023 //
PHARMTECH
Illumina faces EU`s maximum fine for closing Grail deal
13 Jan 2023 //
FIERCE BIOTECH
